title: Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.
authors.affiliation: Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
authors.forename: N K
authors.initials: NK
authors.lastname: Cheung
authors.forename: L
authors.initials: L
authors.lastname: Burch
authors.forename: B H
authors.initials: BH
authors.lastname: Kushner
authors.forename: D H
authors.initials: DH
authors.lastname: Munn
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use* / Q000633:toxicity; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D004341:Drug Evaluation; D006801:Humans; D009000:Monocytes / Q000473:pathology; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D009447:Neuroblastoma / Q000473:pathology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal